January 12, 2017

Hope for metastatic prostate cancer patients: Targeted alpha therapy shows impressive results

Nearly three years of research have brought about remarkable results for the majority of 80 patients subjected to targeted alpha therapy of metastatic prostate cancer. The first assessments — describing a full response in two patients in critical clinical condition with extensive metastases — are published in the December issue of the Journal of Nuclear Medicine (JNM), which has displayed images depicting the improvements on its cover page. {read more here}